Moreover, TGF-β stimulation in MEG-01 cells, which are derived from a CML patient having BCR-ABL fusion protein, and in U937 cells, which are derived from lymphoma, results in suppressed CD48 expression levels and lower susceptibility to NK targeting48. This evidence concerns the gene TGFB1 and lymphoma.